+ All Categories
Home > Documents > Five Key Ingredients: Clinical Leadership Indicative Data Clinical Engagement Evidential Data

Five Key Ingredients: Clinical Leadership Indicative Data Clinical Engagement Evidential Data

Date post: 25-Jan-2016
Category:
Upload: hoang
View: 27 times
Download: 0 times
Share this document with a friend
Description:
- PowerPoint PPT Presentation
Popular Tags:
31
Copyright 2011 Right Care Delivering High Value Pathways Standard versus Optimal – A typical Long-Term Conditions story and how the NHS Right Care approach can help to achieve optimal Professor Matthew Cripps National Programme Director, NHS Right Care Dr Peter Brambleby, Independent public health consultant & Right Care Associate Mr. Anthony Lawton – Right Care Associate
Transcript
Page 1: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

Copyright 2011 Right Care

Delivering High Value Pathways

Standard versus Optimal – A typical Long-Term Conditions story and how the NHS Right Care approach can help to achieve optimal

Professor Matthew CrippsNational Programme Director, NHS Right Care

Dr Peter Brambleby, Independent public health consultant & Right Care Associate

Mr. Anthony Lawton – Right Care Associate

Page 2: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

Five Key Ingredients:

1. Clinical Leadership

2. Indicative Data

3. Clinical Engagement

4. Evidential Data

5. Effective processes

1 key objective + 3 key phases + 5 key ingredients = COMMISSIONING FOR VALUE

2

OBJECTIVE - Maximise Value (individual and population)

Page 3: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

3

Commissioning for Value - Slough CCG

Page 4: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

4

Granularity – Population to Patient

Where to Look How to Change

SDMCare

PlanningManage

care out of hospital

CfV Pack

Atlas

Programme Budgets

Populations Systems

What to Change

Individuals

Deep Dive

Path-way

Provider

Page 5: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

5

Paul’s story – Journey 1

Paul: 45, bricklayer, local employer Smokes 10/day, drinks 4 pints/day, overweightCouncil house, supports Leeds United

Wendy: 42, barmaidDavid: 16, schoolboyGP: small practice, 17 miles from DGHVillage shop: limited food options

Page 6: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

6

Paul’s journey starts when …..

Prompted by Wendy, sees his GP

2 years of increased urinary frequency and loss of energy GP performs tests and confirms diabetes Initial management with diet, exercise, pills 6 visits per year to practice nurse 6 lab tests per year GP has lower than average prescribing and

referral rates – seen as economical

Page 7: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

7

Context & Variation

Page 8: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

8

0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%80.0%

Prac

tice

1Pr

actic

e 6

Prac

tice

11Pr

actic

e 16

Prac

tice

21Pr

actic

e 26

Prac

tice

31Pr

actic

e 36

Prac

tice

41Pr

actic

e 46

Prac

tice

51Pr

actic

e 56

Prac

tice

61Pr

actic

e 66

Prac

tice

71Pr

actic

e 76

Prac

tice

81Pr

actic

e 86

Prac

tice

91Pr

actic

e 96

Prac

tice

101

Prac

tice

106

Prac

tice

111

Achievement (%) of patients with diabetes where HbA1c is 7 or less in previous 15 months

Page 9: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

9

In the local population, who has overall responsibility for:

Preventing diabetes? Raising awareness and screening for diabetes? Quality assurance of diabetes care? Getting best value for money from the investment by

caring agencies in diabetes?

Page 10: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

10

Paul is now 50

Not smoking but still drinking and has not lost weight; recreation is watching football and pub

Has been on insulin for a year Left leg hurts (vascular problem) Not walking far, not driving, missing work Referred to hospital diabetes service and vascular surgeon

– OPD at hospital Wendy drives him David is at university

Page 11: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

11

Spot Tool

Page 12: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

12

Paul is now 52

Leg suddenly goes white and painful; amputated below knee

Significant heart and renal complications Vision deteriorating Loses his job with little chance of retraining Applies for more suitable housing Wendy gives up job David takes a year off university

Page 13: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

13

The Impact (Economic and Social) – Journey 1

Journey 1 - (less than perfect)Paul 45 Paul 50 Paul 52

Yr 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10 Yr 11

Economic Costs - - 1,360 576 576 576 576 1,762 1,953 8,948 32,757 49,084

David takes time out of University to assist the family

Council contacted - alternative housing - rent not affordable

Forced to sell car - so Wendy also less mobile

Personal & Emotional Costs

Excessive drinking

ObeseLeft leg - white & very painful (then

amputated)

Loses job

Left leg pain

Missing work days

Stopped exercising

Stopped drivingWendy taking half days off to

drive to treatments / Economic situation of the family

becoming tough

Excessive drinking

Obese

Obese

Smoking

Excessive drinking (reduced)

Obese (but improved)

Smoking (reduced)

Pre Primary Care Review

Increased urinary frequency

Issues around Thirst

Excessively Tired

Excessive drinking

Excessive drinking

Obese

Phase 1 Activity & Treatment Phase 2 Activity & Treatment Phase 3 Activity & Treatment

Economic situation of the family is now extreme

Paul's quality of life now very poor

Both Paul & Wendy depressed

Cant exercise

Cant drive

Wendy taking more time off as carer

Page 14: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

14

The Economic Impact during 3 of those 11 years

Economic Analysis - Journey 1 Extracts:

Activity Costs Activity Costs Activity Costs

GP Visit 4 30.66 GP Visit 3 23.00 GP Visit 3 23.00

Diet advice 1 17.39 GP Care plan review 1 11.50 GP Care plan review 1 11.50

Exercise advice 1 17.39 Prescription Drugs 1 370.52 Prescription Drugs 1 370.52

Prescription Drugs 1 370.52 Testing Strips 1 9.89 Testing Strips 1 9.89

Testing Strips 1 9.89 Lab Tests 2 252.00 Lab Tests 3 378.00

Lab Tests 6 756.00 Practice Nurse 6 34.78 Practice Nurse 6 34.78

Practice Nurse 6 34.78 Daily insulin injections (Levemir) 1 715.00 Daily insulin injections (Levemir) 1 715.00

District Nurse Visit 0 - Diabetology clinic 1 50.00 Diabetology clinic 1 50.00

Care Plan developed 1 23.00 Diabetes specialist nurse 1 7.73 Diabetes specialist nurse 1 7.73

Retinopathy screening 1 100.00 Referred to vascular clinic (Registrar) 1 235.00

Treatment - Heart disease (investigative procedure) 1 210.00

Retinopathy screening follow up 1 53.00 Treatment - Renal Impairment (initial dialysis - monthly) 1 3,012.00

Treatment - Eye disease (glasses) 1 50.00

Anti depressants prescribed 2 107.76

NHS Transport (Ambulance) 4 854.00 Leg ulcer treatment (septicaemia) 1 3,114.00

1,359.63 1,762.42 8,948.18

Phase 1 - Yr 3 Phase 2 - Yr 8 (Paul at 50) Phase 3 - Yr 10 (Paul at 52)

Page 15: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

15

Paul’s story: What the CCG have done – Commissioning for Value CCG have used CfV pack, identified Diabetes as a key

improvement priority

Worked with AT and neighbouring CCGs to ensure wider system improvement (whilst not allowing this to slow progress for their own population)

Engaged the right people, conducted a deep dive and service review, identified what needed to change, built the case, took the decisions and implemented the change

What does the next Paul’s journey look like now?

Page 16: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

16

Paul’s story - Journey 2

NHS Health Check identifies Paul’s condition at the end of year 1 – Case management begins…

Use of specialist clinics for advice on diet and exercise (10x cost of GP advice) and this repeated every 2 years

Care Plan / Medication / Retinopathy Screening brought forward 18 months compared to Journey 1

Self Management – Desmond Programme

Diabetes Patient Support Group set up locally

Page 17: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

17

The Impact (Economic and Social) J2Journey 2 - (Improved Pathway - Revised Focus)

Pre Primary Yr 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10 Yr 11

Increased urinary frequency

Excessive drinking (reduced)

Issues around Thirst

Obese (but improved)

Excessively Tired

Smoking (reduced)

Excessive drinking

Obese

Smoking

Economic Costs 23 1,153 607 958 587 958 710 1,084 736 1,210 909 8,936

Phase 1 Activity & Treatment

Support working - Eating well, Exercising, & Drinking Controlled. Keeping work and social life healthy, no depression, no serious interventions:

focus is on Support, Education & Medication.Personal & Emotional Costs

Phase 2 Activity & Treatment Phase 3 Activity & Treatment

Initial pathway = sub-optimal quality, cost £49k, low valuePost-improvement = optimal quality, cost £9k, high value

Page 18: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

18

Discussion Points

Type two diabetes is a largely preventable disease caused, and controlled, by lifestyle

Better “vertical” integration (along the clinical pathway) and “horizontal” integration (between the parties) could improve outcomes and save substantial costs

Who should take the initiative for the individual and for the population?

Page 19: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

19

Granularity – Population to Patient

Where to Look How to Change

SDMCare PlanningManage care out of hospital

CfV PackAtlas

Programme

Budgets

Populations

Systems

What to Change

Individuals

Deep Dive

Path-way

Provider

Page 20: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

20

CURRENTSERVICE

FUTURESERVICE

Fit forPurpose

Efficiencyand

marketoptions

Supplyand

capacityoptions

No/ lowbenefit

Step 1 – define:

Step 3 –

categorise:

Step 2 – define:

Redesign,Contract,Procure

Contract,Procure,Divest

Step 4 –

recommend:

Maintain

Divest

Service Review Pathway – Diagnostic steps

Fit forPurpose

Efficiencyand

marketoptions

Supplyand

capacityoptions

Page 21: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

21

Respiratory Care in Warrington Health Economy

• 2010/11 –• £1.5M Overspending V. demographic peers• Only 2/3s of asthmatics known• Worst quintiles – COPD rate of em admns, deaths

within 30 days, %age receiving NIV, re-admns

• 2012/13 –• £0.6M UNDER spending V. demographic peers• Delivered by focus on variation – problems fixed or

improving (e.g. 30% less COPD NEL admissions, MDT, 70+ p.m. triaged away from acute sector)

• HSJ Commissioner of the Year

Page 22: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

22

Where Bradford are now (and where West Cheshire were)…

Page 23: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

23

Where West Cheshire are now (and where you could be)…

Page 24: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

24

Number of Circulatory indicators in the bottom quintile of the practice cluster

Note, some of the data are based on small numbers. Statistical significance has not been tested and should not be inferred. The data are presented to identify potential areas of improvements rather than providing a definitive

comparison of performance.

Each coloured bar represents a different set of indicators e.g. dark blue is prevalence. The specific indicators are then shown in the table on slides 21-27 for the 3 practices with the highest total number of indicators in the bottom quintile

1

Galvanising Clinicians – On the right things

Page 25: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

25

Change the clinical perspective

Dr Jones is a Derby-based respiratory physician. Last year she saw 346 people with COPD and provided evidence based, patient centred care

Page 26: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

26

All people with the condition

People receiving the specialist service

She estimated that there are 1000 people with COPD in South Derbyshire and a population based audit showed that there were 100 people who were not referred who would benefit from the knowledge of her team

People receiving the service

People who would benefit most from the service

Page 27: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

27

Dr Jones is given a day a week for Population Respiratory Health and the local COPD Network and Service helps her to increase population value by:

Working with Public Health to reduce smoking Network development Improving the quality of patient information Professional development of all system staff (e.g. nurse

educators) Production of the Annual Report of the service

Page 28: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

28

Work through the phases and Commission for Value

Where to Look How to Change

SDMCare

PlanningManage

care out of hospital

CfV Pack

Atlas

Programme Budgets

Populations Systems

What to Change

Individuals

Deep Dive

Path-way

Provider

Page 29: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

29

Page 30: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

30

Where can I find out more?

• The Powerpoint presentation you have seen today, an excel spreadsheet with the underlying data is available on the Right Care website

• You will also find there links to short online learning videos on the Right Care approach and links to some of the tools and packs mentioned in the presentation

• Email Feedback or questions to [email protected]

• Or Visit and follow the link

www.rightcare.nhs.uk/paul_adams

Page 31: Five Key Ingredients: Clinical  Leadership Indicative Data Clinical Engagement Evidential Data

31

For more information – contact the team

Professor Matthew Cripps - National Programme Director,

NHS Right Care

Email: [email protected]

Dr Peter Brambleby, Independent public health consultant,

Email: [email protected]

Mr. Anthony Lawton – Right Care Associate

Email: [email protected]

Jules Gaughan - Right Care Associate

Email: [email protected]

Mr. Ian McKinnell - NHS Right Care

Email: [email protected]


Recommended